Strata Critical Medical, Inc. (SRTA) - Net Assets
Based on the latest financial reports, Strata Critical Medical, Inc. (SRTA) has net assets worth $285.73 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($327.62 Million) and total liabilities ($41.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Strata Critical Medical, Inc. strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $285.73 Million |
| % of Total Assets | 87.21% |
| Annual Growth Rate | 95.46% |
| 5-Year Change | -4.22% |
| 10-Year Change | N/A |
| Growth Volatility | 934.84 |
Strata Critical Medical, Inc. - Net Assets Trend (2019–2025)
This chart illustrates how Strata Critical Medical, Inc.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of Strata Critical Medical, Inc..
Annual Net Assets for Strata Critical Medical, Inc. (2019–2025)
The table below shows the annual net assets of Strata Critical Medical, Inc. from 2019 to 2025. Also explore how fast is Strata Critical Medical, Inc. growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $279.07 Million | +25.74% |
| 2024-12-31 | $221.94 Million | -5.28% |
| 2023-12-31 | $234.30 Million | -14.64% |
| 2022-12-31 | $274.49 Million | -5.79% |
| 2021-12-31 | $291.37 Million | +2529.70% |
| 2020-12-31 | $11.08 Million | +121.60% |
| 2019-12-31 | $5.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Strata Critical Medical, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18646.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.00K | 0.00% |
| Other Components | $424.62 Million | 152.15% |
| Total Equity | $279.07 Million | 100.00% |
Strata Critical Medical, Inc. Competitors by Market Cap
The table below lists competitors of Strata Critical Medical, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Djurslands Bank
CO:DJUR
|
$446.53 Million |
|
Taiyuan Lionhead Cement Co Ltd
SHG:600539
|
$446.62 Million |
|
Xiamen Savings Environmental
SHE:300056
|
$446.76 Million |
|
Chun Yuan Steel Industry Co Ltd
TW:2010
|
$446.86 Million |
|
Consolidated Water Co. Ltd
F:CW2
|
$446.41 Million |
|
Hampidjan hf
IC:HAMP
|
$446.23 Million |
|
Shandong Tongda Island New Materials Co Ltd
SHE:300321
|
$446.22 Million |
|
Guangdong Huiyun Titanium Industry
SHE:300891
|
$446.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Strata Critical Medical, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 221,938,000 to 279,072,000, a change of 57,134,000 (25.7%).
- Net income of 41,347,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 1,753,000.
- Other factors increased equity by 17,540,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $41.35 Million | +14.82% |
| Other Comprehensive Income | $-1.75 Million | -0.63% |
| Other Changes | $17.54 Million | +6.29% |
| Total Change | $- | 25.74% |
Book Value vs Market Value Analysis
This analysis compares Strata Critical Medical, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.59x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7.92x to 1.59x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.68 | $5.38 | x |
| 2020-12-31 | $0.89 | $5.38 | x |
| 2021-12-31 | $4.16 | $5.38 | x |
| 2022-12-31 | $3.85 | $5.38 | x |
| 2023-12-31 | $3.19 | $5.38 | x |
| 2024-12-31 | $2.86 | $5.38 | x |
| 2025-12-31 | $3.38 | $5.38 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Strata Critical Medical, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.82%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 20.97%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 1.17x
- Recent ROE (14.82%) is above the historical average (-50.51%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -216.76% | -34.74% | 0.11x | 55.54x | $-11.34 Million |
| 2020 | -91.70% | -43.36% | 1.32x | 1.60x | $-11.27 Million |
| 2021 | -13.75% | -79.27% | 0.15x | 1.15x | $-69.19 Million |
| 2022 | -9.93% | -18.66% | 0.45x | 1.18x | $-54.71 Million |
| 2023 | -23.93% | -24.90% | 0.76x | 1.26x | $-79.51 Million |
| 2024 | -12.30% | -10.98% | 0.97x | 1.16x | $-49.50 Million |
| 2025 | 14.82% | 20.97% | 0.61x | 1.17x | $13.44 Million |
Industry Comparison
This section compares Strata Critical Medical, Inc.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $603,309,672
- Average return on equity (ROE) among peers: -3.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Strata Critical Medical, Inc. (SRTA) | $285.73 Million | -216.76% | 0.15x | $446.48 Million |
| Acadia Healthcare Company Inc (ACHC) | $2.90 Billion | 9.42% | 0.72x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $706.69 Million | 8.85% | 0.45x | $1.69 Billion |
| agilon health Inc (AGL) | $-232.03 Million | 0.00% | 0.00x | $1.50 Billion |
| Airsculpt Technologies Inc (AIRS) | $87.71 Million | -13.30% | 1.14x | $165.82 Million |
| Amedisys Inc (AMED) | $1.11 Billion | 10.72% | 0.79x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $170.84 Million | -71.51% | 1.28x | $624.22 Million |
| American Shared Hospital Service (AMS) | $15.99 Million | 6.89% | 1.80x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $325.24 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.05 Billion | 17.99% | 3.63x | $1.53 Billion |
| Astrana Health Inc (ASTH) | $-17.74K | 0.00% | 0.00x | $1.70 Billion |
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including … Read more